Simplex Trading’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-3,049
Closed -$57K – 8386
2019
Q1
$57K Buy
+3,049
New +$49.5K ﹤0.01% 4912
2017
Q2
– Sell
-27,970
Closed -$134K – 7460
2017
Q1
$134K Buy
+27,970
New +$152K 0.01% 1508
2016
Q4
– Sell
-219
Closed -$1.12K – 7225
2016
Q3
$1K Buy
+219
New +$1.12K ﹤0.01% 5673
2016
Q2
– Sell
-6,725
Closed -$36.2K – 7085
2016
Q1
$38K Sell
6,725
-1,913
-22% -$13.4K ﹤0.01% 2218
2015
Q4
$89K Buy
8,638
+6,907
+399% +$93.7K 0.01% 1455
2015
Q3
$31K Buy
1,731
+1,546
+836% +$29.8K ﹤0.01% 2381
2015
Q2
$3K Buy
185
+37
+25% +$655 ﹤0.01% 4213
2015
Q1
$2K Sell
148
-3,484
-96% -$58.5K ﹤0.01% 4339
2014
Q4
$58K Buy
+3,632
New +$48.6K 0.01% 1282

Other funds holding OSIR

Simplex Trading's OSIR Position: Q2 2019 in Review

Simplex Trading sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 3,049 shares — an estimated $57K sold.

Simplex Trading first reported a position in OSIR in Q4 2014 and held it in 9 quarters. The position peaked at $134K in Q1 2017. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Simplex Trading reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Simplex Trading sold 3,049 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $57K.
  • Simplex Trading first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2014 and held it in 9 quarters.
  • Simplex Trading's Osiris Therapeutics, Inc. Common Stock position peaked at $134K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.